Monday, August 29, 2016

Low-Dose Naltrexone for Lyme treatment

I have mentioned this before in my blog, but saw an email with some links in it today so thought it's high time for me to re-post something here about it. 

Naltrexone, a cancer drug, is used in low doses for treating inflammation.

This one from Dr. Mercola:

Low-Dose Naltrexone (LDN): One of the RARE Drugs that Actually Helps Your Body to Heal Itself

This from the Clinical Rheumatology (2014)

The use of low-dose naltrexone (LDN) as a novel anti-inflammatory treatment for chronic pain

And this site apparently run by David Gluck, MD of NYC.

Thursday, August 25, 2016

Nematodes and spirochetes in brains of cadavers

This is the work of Alan MacDonald and Tom Grier related to findings of nematodes and spirochetes in brains of cadavers.

Tuesday, August 23, 2016

Letter by Dorothy Leland rebuttal to Daily Republic news article on Lyme

Dorothy wrote an excellent article, and I'm very glad she refuted Scott Anderson. I tried multiple times to post a comment, but the link does not respond.

— Virginia

Check it out!

Write a response!

You probably didn't see the article that inspired her to write it. Its title is 

Long-term antibiotics not helpful in treating Lyme disease
One of the things the author states is a common myth, since research says up to half the patients continue to have chronic symptoms, not "a minority."

He wrote: "There is a minority of patients, however, who are diagnosed with chronic Lyme disease," 

Daily Republic published it in June and it had only 2 comments.

It was good of them to give Dorothy this opportunity.

Now go and comment so the paper knows we care.

Phyllis Mervine,   CaliforniaLyme

Friday, August 19, 2016

Stevia Kills Lyme Disease Pathogen Better Than Antibiotics (Preclinical Study) | GreenMedInfo | Blog Entry

Posted on:

Lyme disease is exceedingly difficult to treat, due to its well-known shape-shifting (pleomorphic) abilities, with conventional antibiotics often failing to produce a long-term cure. Could the commonly used natural plant Stevia provide a safer, and more effective means to combat this increasingly prevalent infection?

A promising new preclinical study has revealed that whole stevia leaf extract possesses exceptional antibiotic activity against the exceedingly difficult to treat pathogen Borrelia Burgdorferi known to cause Lyme disease. The study found...

Read here:

Gut Microbes and the Brain: Paradigm Shift in Neuroscience


The discovery of the size and complexity of the human microbiome has resulted in an ongoing reevaluation of many concepts of health and disease, including diseases affecting the CNS. A growing body of preclinical literature has demonstrated bidirectional signaling between the brain and the gut microbiome, involving multiple neurocrine and endocrine signaling mechanisms. While psychological and physical stressors can affect the composition and metabolic activity of the gut microbiota, experimental changes to the gut microbiome can affect emotional behavior and related brain systems. These findings have resulted in speculation that alterations in the gut microbiome may play a pathophysiological role in human brain diseases, including autism spectrum disorder, anxiety, depression, and chronic pain. Ongoing large-scale population-based studies of the gut….

See the study:

Laser Therapy a New Hope for PARKINSON’S DISEASE

Aggregates of alpha-synuclein in brain cells of people with Parkinson's disease have long been the target of research hoping to cure or at least alleviate the symptoms of dementias often associated with Parkionson's.  Newly publicized research from Chalmers University of Technology in Sweden together with Wroclaw University of Technology in Warsaw, Poland found that it is possible to use a laser driven technology to distinguish the formations of alpha-synuclein proteins from the formations of other functionally beneficial and necessary proteins in the brain.  The same technique, called "multi-photon laser technique" could also be used to eliminate those aggregated proteins…

Read the rest of the story here:

Monday, August 8, 2016

Lyme Advocates Petition CDC

Washington, DC – WEBWIRE – 
Preferential treatment provided by CDC to IDSA violates the federal law that governs the conduct of Executive Branch employees.
Preferential treatment provided by CDC to IDSA violates the federal law that governs the conduct of Executive Branch employees.

Because of CDC policy failures, mismanagement and violations of federal law, hundreds of thousands of Lyme patients experience a greatly diminished quality of life—a tragedy compounded by financial hardships from out-of-pocket costs and lost income. The burden on individuals as well as on our economy is enormous, the suffering is widespread and much of this is preventable.

A D.C. based citizens action group wants the Centers for Disease Control (CDC) in Atlanta to change its stance on the treatment of Lyme disease in the United States.

The Patient Centered Care Advocacy Group filed a "citizen petition" with the Centers for Disease and Control Prevention calling on it to end the preferential treatment it extends to the Infectious Diseases Society of America (IDSA) guidelines for diagnosis and treatment of Lyme disease. The petition was filed in accordance with the Administrative Procedure Act (APA), which governs the conduct of the federal government.

According to the petition, the CDC....

Read the rest of the story here: